Newron Pharmaceuticals (Switzerland) Today
| NWRN Stock | CHF 7.50 0.41 5.78% |
Performance0 of 100
| Odds Of DistressOver 61
|
Newron Pharmaceuticals is selling for under 7.50 as of the 28th of November 2024; that is 5.78% up since the beginning of the trading day. The stock's lowest day price was 6.91. Newron Pharmaceuticals has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Newron Pharmaceuticals SpA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system in Italy and internationally. The company was founded in 1998 and is headquartered in Bresso, Italy. The company has 17.85 M outstanding shares. More on Newron Pharmaceuticals SpA
Moving against Newron Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Newron Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Newron Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Newron Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Newron Pharmaceuticals SpA (NWRN) is traded on SIX Swiss Exchange in Switzerland and employs 25 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Newron Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Newron Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Newron Pharmaceuticals operates under Healthcare sector and is part of Biotechnology industry. The entity has 17.85 M outstanding shares.
Newron Pharmaceuticals SpA has accumulated about 58.99 M in cash with (11.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31.
Check Newron Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationNewron Pharmaceuticals maintains a total of 17.85 Million outstanding shares. Newron Pharmaceuticals SpA secures 4.96 % of its outstanding shares held by insiders and 7.28 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Newron Ownership Details
Newron Pharmaceuticals Risk Profiles
Although Newron Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Newron Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.36 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.2 | |||
| Risk Adjusted Performance | (0.01) |
Newron Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Newron Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Newron Pharmaceuticals Corporate Management
Elected by the shareholders, the Newron Pharmaceuticals' board of directors comprises two types of representatives: Newron Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Newron. The board's role is to monitor Newron Pharmaceuticals' management team and ensure that shareholders' interests are well served. Newron Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Newron Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ravi Anand | Chief Officer | Profile | |
| Roberto Galli | VP Fin | Profile | |
| Stefan Weber | CEO Director | Profile | |
| Marco Caremi | Exec Devel | Profile |
Additional Tools for Newron Stock Analysis
When running Newron Pharmaceuticals' price analysis, check to measure Newron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newron Pharmaceuticals is operating at the current time. Most of Newron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.